OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Biomarkers for Early Detection of Chronic Kidney Disease
Maja Mizdrak, Marko Kumrić, Tina Tičinović Kurir, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 4, pp. 548-548
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Cost-effectiveness of screening for chronic kidney disease in the general adult population: a systematic review
See Cheng Yeo, Hankun Wang, Gary Ang, et al.
Clinical Kidney Journal (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 29

A Synopsis of Current Theories on Drug-Induced Nephrotoxicity
Łukasz Dobrek
Life (2023) Vol. 13, Iss. 2, pp. 325-325
Open Access | Times Cited: 25

Urinary biomarkers in kidney disease
Esra Canki, Esther Kho, Joost G.J. Hoenderop
Clinica Chimica Acta (2024) Vol. 555, pp. 117798-117798
Open Access | Times Cited: 12

Serum and urinary uromodulin concentration in children and young adults with chronic kidney disease
Sonja Golob Jančič, Mirjam Močnik, Martina Filipič, et al.
Pediatric Nephrology (2025)
Closed Access | Times Cited: 1

Hypertension Related Co-Morbidities and Complications in Women of Sub-Saharan Africa: A Brief Review
Taija Hahka, Rebecca Slotkowski, Anum Akbar, et al.
Circulation Research (2024) Vol. 134, Iss. 4, pp. 459-473
Closed Access | Times Cited: 8

Saliva as Biomarker for Oral and Chronic Degenerative Non-Communicable Diseases
Michele Basilicata, Massimo Pieri, Giulia Marrone, et al.
Metabolites (2023) Vol. 13, Iss. 8, pp. 889-889
Open Access | Times Cited: 16

Biomarkers of chronic kidney disease in older individuals: navigating complexity in diagnosis
Lucia Muglia, Michele Di Dio, Elvira Filicetti, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 5

Exosomal UMOD gene expression and urinary uromodulin level as early noninvasive diagnostic biomarkers for diabetic nephropathy in type 2 diabetic patients
Shaimaa I. Barr, Sahar S. Bessa, Tarek M. Mohamed, et al.
Diabetology International (2024) Vol. 15, Iss. 3, pp. 389-399
Closed Access | Times Cited: 4

CYSTATIN C—A Monitoring Perspective of Chronic Kidney Disease in Patients with Diabetes
Alexandra-Mihaela Visinescu, Emilia Rusu, Andrada Coșoreanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8135-8135
Open Access | Times Cited: 4

Predictive markers in chronic kidney disease
G. Priyadarshini, Medha Rajappa
Clinica Chimica Acta (2022) Vol. 535, pp. 180-186
Closed Access | Times Cited: 17

Diagnostic methods employing kidney biomarkers clinching biosensors as promising tools
Neelam Yadav, Jagriti Narang, Anil Kumar Chhillar, et al.
Sensors International (2023) Vol. 5, pp. 100253-100253
Open Access | Times Cited: 10

The relationship between water intake and the progression of urine albumin-creatinine ratio in patients with chronic kidney disease: A cohort-prospective study.
Mulyanti Sulastri Yanti, Haerani RASYID, Aminuddin Aminuddin, et al.
Nutrición clínica y dietética hospitalaria/Nutrición clínica, dietética hospitalaria (2025) Vol. 45, Iss. 1
Closed Access

A Mini Review: Role of Novel Biomarker for Kidney Disease of Future Study
Palash Mitra, Sahadeb Jana, Suchismita Roy
Advances in Biomarker Sciences and Technology (2025)
Open Access

sCD14 as a biomarker for the progression of kidney disease among patients with diabetes
Óscar Zaragoza-García, Olivia Briceño, José Rafael Villafán-Bernal, et al.
Journal of Diabetes and its Complications (2025) Vol. 39, Iss. 3, pp. 108980-108980
Closed Access

PFAS Exposure and Kidney Health with Gut Microbiota, Blood Metabolites, and Multi-Organ Implications Across Medical Specialties
Nicholas A Kerna, Adina Boulos, Melany Abreu, et al.
European journal of ecology, biology and agriculture. (2025) Vol. 2, Iss. 2, pp. 30-46
Closed Access

Recent advancements in patented technologies for the diagnosis and treatment of chronic kidney disease
Poornima Bhatt, Monika Chhillar, Akshit Kumar, et al.
International Urology and Nephrology (2025)
Closed Access

Insights into diabetic nephropathy biomarkers with focus on existing indices and potential future developments
Ahmed Olatunde, Kaliyaperumal Saravanan, Olalekan Bukunmi Ogunro, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access

Protective Effect of Fumaria Extract on Molecular and Histological Damage and Oxidative Stress Induced by Ischemia/Reperfusion in Adult Rat Kidneys
Linda Mophammadzadeh Boukani, Mohammad Rezaei, Mahtab Ghaemi, et al.
Crescent Journal of Medical and Biological Sciences (2025) Vol. 12, Iss. 2, pp. 79-84
Closed Access

Salivary microbiome in chronic kidney disease: what is its connection to diabetes, hypertension, and immunity?
Fengping Liu, Jiayi Sheng, Lei Hu, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 15

Can immature granulocytes and neutrophil-lymphocyte ratio be biomarkers to evaluate diabetic nephropathy?: A cross-sectional study
Fatih Yay, Ergül Bayram, Hünkar Ağgül, et al.
Journal of Diabetes and its Complications (2024) Vol. 38, Iss. 9, pp. 108807-108807
Closed Access | Times Cited: 3

Pyruvate Kinase M2: A New Biomarker for the Early Detection of Diabetes-Induced Nephropathy
Yeon Su Park, Joo Hee Han, Jae Hyeon Park, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2683-2683
Open Access | Times Cited: 8

Optimized Ensemble Machine Learning Model for Chronic Kidney Disease Prediction
Chahil Choudhary, Lovepreet Singh Nagra, Prasenjit Das, et al.
2022 International Conference on Computing, Communication, and Intelligent Systems (ICCCIS) (2023), pp. 292-297
Closed Access | Times Cited: 8

The Geroprotective Drug Candidate CMS121 Alleviates Diabetes, Liver Inflammation, and Renal Damage in db/db Leptin Receptor Deficient Mice
Saadia Zahid, Alcir Luiz Dafré, António Currais, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6828-6828
Open Access | Times Cited: 7

Genomic insights into renal diseases: advancements and implications
Nicholas Aderinto, Gbolahan Olatunji, Emmanuel Kokori, et al.
The Egyptian Journal of Internal Medicine (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top